News
Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on the Hong Kong Stock Exchange at HK$44 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback